Premarket Mover: Seres Therapeutics Inc (MCRB) Up 2.11%

Seres Therapeutics Inc (MCRB) is up Monday morning, with the stock climbing 2.11% in pre-market trading to 1.45. MCRB's short-term technical score of 45 indicates that the stock has traded less bullishly over the last month than 55% of stocks on the market. In the Biotechnology industry, which ranks 120 out of 146 industries, MCRB ranks higher than 62% of stocks. Seres Therapeutics Inc has remained neutral 0.00% over the past month, closing at $1.53 on October 23. During this period of time, the stock fell as low as $0.93 and as high as $1.63. MCRB has an average analyst recommendation of Strong Buy. The company has an average price target of $11.25.

MCRB has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on MCRB!

See Full MCRB Report

Seres Therapeutics Inc has a Long-Term Technical rank of 3. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 97% of the market scoring higher. In the Biotechnology industry which is number 130 by this metric, MCRB ranks better than 130% of stocks.

Important Dates for Investors in MCRB:

-Seres Therapeutics Inc is set to release earnings on 2024-01-31. Over the last 12 months, the company has reported EPS of $-1.21. -We do not have a set dividend date for Seres Therapeutics Inc at this time. Click Here To Get The Full Report on Seres Therapeutics Inc (MCRB)